Telix Pharmaceuticals Ltd. (AU:TLX) has released an update.
Telix Pharmaceuticals Limited has announced the application for quotation of 104,500 new fully paid ordinary shares on the ASX under the security code TLX, dated June 27, 2024. This move signals a potential expansion of investment opportunities for those interested in the healthcare sector.
For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.
